Royal DSM, a global science-based company active in health, nutrition and materials, headquartered in the Netherlands, will bring innovative solutions to the biofuels industry with a full portfolio offering of yeast and enzymes for starch, fiber and biomass conversions.
Novozymes launched two new enzymes for the European ethanol market. The two products (Spirizyme® 2.0 T and Spirizyme Ultra T) are part of the Spirizyme T Portfolio, an advanced suite of glucoamylase enzymes with trehalase that deliver yield enhancing activities documented to provide the highest total sugar conversion in the industry.
Novozymes launched the Spirizyme® T Portfolio, an advanced suite of glucoamylase enzymes with trehalase and other yield enhancing activities that provide the most total sugar conversion in the industry. Trehalase is an enzyme that converts trehalose, a type of sugar that cannot be fermented to ethanol, to glucose, which is easily fermentable.
Clariant’s cellulosic ethanol using sunliquid® technology can achieve price competitiveness with sugarcane ethanol pricing in Brazil. To say it is the Swiss chemical company in a note.
Novozymes today announced the launch of Avantec® Amp, an advanced enzyme product that improves yield and throughput in corn ethanol production, while increasing corn oil extraction and significantly reducing the need for several harsh chemicals used in ethanol production. By switching from standard enzyme technology to Avantec Amp, a typical ethanol plant with a capacity of 110 million gallons can make up to $2.5 million a year in additional net profits.
DuPont Industrial Biosciences and Quad County Corn Processors (QCCP) announced a new multi-year contract to supply the enzymes that enable QCCP’s Cellerate™ process in the production of cellulosic biofuel from corn kernel fiber.
Denmark’s Novozymes , the world’s largest enzymes producer, will stick to its plans to develop transportation fuel made from agricultural waste, despite an oil price rout that has left oil-based products cheaper for consumers. Some analysts have expressed concern that a lower crude oil price might dampen investor interest in alternatives, but Novozymes said on Thursday that it aims to provide enzymes to 15 advanced bioethanol plants by 2017, up from five, generating 1 billion Danish crowns ($165.7 million) in revenue.
Dyadic International, a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced that it has launched Fibrezyme® G4, a high performance cellulase enzyme product designed to enhance paper and textile quality, while improving the economics of our customers’ manufacturing processes.
Novozymes – the Danish biotech company which is world leader in industrial enzymes – announced yesterday the launch of a new enzyme solution (LpHera) that helps make starch conversion more efficient. The starch industry is one of the longest-standing markets for enzymes, and within the food industry helps to produce a wide range of sweeteners and ingredients used in products ranging from soft drinks to sauces.
“The central question for the development of any new field, such as the bioeconomy, is: ‘Who’s going to do it?’ Which countries and which companies are going to make the investments and do the hard development work to achieve the technology and the infrastructure which are necessary to move forward? Technologies are important, feedstocks are important, but at the end of the day it is all about who has the will and motivation to fund and develop these systems”. To say it in this exclusive interview with Il Bioeconomista is Daniel Gibbs, Founder and Ceo of the General Biomass Company, which is currently developing advanced industrial enzymes and other technology to convert nonfood cellulosic feedstocks to sugars for bioplastics, sustainable packaging, renewable chemicals and biofuels. With Gibbs we talk about the bioeconomy in US, the different roles played by America, Europe and Asia, considering the strategic role of cheap nonfood biomass to the further development of the bioeconomy. “We need to realize- says Gibbs – that production of biobased chemicals and plastics from biomass may be a very significant driver of technology development, since the monomers for bioplastics have a higher oxygen content and thus a higher yield than the alkanes needed, e.g., for biojetfuel or biodiesel. Both chemically and financially, this becomes attractive for consumer brands and sustainable packaging
Interview by Mario Bonaccorso